Financhill
Back

DoubleVerify Holdings Vs. Viking Therapeutics Industry Stock Comparison

Sell
36

DV
DoubleVerify Holdings

Last Price:
18.15
Seasonality Move:
-2.78%
Sell
47

VKTX
Viking Therapeutics

Last Price:
54.13
Seasonality Move:
8.99%
Sell
36
DoubleVerify Holdings (DV) is a Sell

Is DoubleVerify Holdings a Buy, Sell or Hold?

  • The current DoubleVerify Holdings [DV] share price is $18.12. The Score for DV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • DV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $54.16. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DV Stock Price Chart

What is DoubleVerify Holdings's stock price today?

  • The DoubleVerify Holdings share price today is $18.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DV is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $54.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

DV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 36.36 Sell
Chaikin Money Flow: -1333093 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.59 - 19.65) Sell
Bollinger Bands (100): (16.96 - 25.08) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 40.93 Sell
Chaikin Money Flow: 868119 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.37 - 63.73) Sell
Bollinger Bands (100): (52.14 - 69.1) Sell

DV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.25 Sell
20-day SMA: 19.1 Sell
50-day SMA: 19.62 Sell
200-day SMA: 28.48 Sell
8-day EMA: 19.07 Sell
20-day EMA: 19.25 Sell
50-day EMA: 19.82 Sell
200-day EMA: 25.34 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.42 Sell
20-day SMA: 60.55 Sell
50-day SMA: 56.97 Sell
200-day SMA: 50.23 Buy
8-day EMA: 58.53 Sell
20-day EMA: 59.39 Sell
50-day EMA: 58.62 Sell
200-day EMA: 50.21 Buy

DoubleVerify Holdings Earnings Growth & DV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.04 per share, an increase this year of $0.17 per share, and an increase next year of $0.15 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.59 per share.

DoubleVerify Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):